GBT440-034 Sickle Cell Disease

Sickle Cell

Protocol:GBT440-034

Condition or Disease: Sickle Cell Disease

Study Type: Interventional (Clinical Trial)

Status: Open for enrollment

Study Title: An Open Label Extension Study GBT440 administered Orally to Patients with Sickle Cell Disease Who Have Participate in GBR440 Clinical Trials.

Principal I investigator: Alan Ikeda, MD

More Info: //clinicaltrials.gov/ct2/show/NCT03573882

Share This Post

Share on facebook
Share on linkedin
Share on twitter
Share on email

Explore More News

Blog

Cure 4 The Kids Foundation Adds Dr. Suraj Pratap To Its Team of Exceptional Providers

Cure 4 The Kids Foundation (C4K) is pleased to announce the addition of Dr. Suraj Pratap, M.D. to their team of healthcare providers. Dr. Pratap brings with him a wealth of experience, having previously practiced general pediatrics in Las Vegas. He recently obtained his board-certification in pediatric hematology oncology, which will provide additional resources and expertise to C4K’s existing team of seven providers. Fluent in both English and Hindi, Dr. Pratap is now seeing C4K patients.